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Renal denervation (RDNx) lowers mean arterial pressure
(MAP) in a number of models of hypertension. Less well
studied is the effect of celiac ganglionectomy (CGx), a
procedure that has proven equally effective at lowering MAP
in some animal models. In this study, we hypothesized that
RDNx and CGx would both lower MAP in genetically
hypertensive Schlager (BPH/2J) mice and that this would
correlate with a decrease in sympathetic activity. BPH/2J
mice underwent radiotelemeter implantation for monitoring
of MAP followed by a 7-10 day convalescence period, after
which control data was collected for 2 days. Next, mice were
randomly subjected to one of three treatments: RDNx, CGx,
or sham. MAP and heart rate were recorded for 14 days post-
operatively. Baseline MAP in the three groups was similar
(~130mmHg). On post-operative day 14, MAP in both RDNx
(-13 ± 2 mmHg) and CGx (-8 ± 0.3 mmHg) decreased, but
was not affected in sham controls (-6 +/- 10 mmHg). The
change in heart rate (beats/min) was not different between
groups 14 days after surgery (-24 ± 4 in sham, -21 ± 33 in
RDNx and -41 ± 18 in CGx). To assess the effect of RDNx on
renal cytokines in BPH/2J hypertension, tissues were
collected from RDNx, CGx, and sham-treated animals two
weeks post-treatment in order to confirm the efficacy of the
denervations. Future studies will explore the mechanism of
how targeted sympathetic ablation changes MAP.
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Renal denervation and celiac ganglionectomy will lower mean 
arterial pressure (MAP) in BPH/2J mice due to a decrease in 
sympathetic nerve activity to their respective renal and 
splanchnic vascular beds.
Mice were implanted with radiotelemeters. They were then given
a 7-10 day convalescence period, after which baseline MAP and
HR data were collected for two days. At the end of control day 2,
the mice received injections of hexamethonium (10 mg/kg, IP).
After a minimum of 3 hours of recovery, mice were randomly
assigned to one of three treatment groups (RDNx, CGx, sham)
and underwent the corresponding surgeries. Data was collected
for 14 days post-operatively, after which the animals were
euthanized. Tissues were collected at this time in order to verify
the efficacy of the treatment surgeries using high performance
liquid chromatography (HPLC) to analyze the norepinephrine
content of the tissues. An effective surgery was one in which the
norepinephrine levels had fallen to 10% of control values.
Grant support: R01-HL 067357-15 and R01 HL 116476-02. Additional support from the University of 
Minnesota Undergraduate Research Opportunities Program. Thanks to Dusty Van Helden, Chris
Banek, Robert Brunette and Claire Breitenstein for their input and technical support.
Since RDNx and CGx decreased MAP, we can conclude that the
renal nerves contribute to the high baseline MAP in Schlager mice.
Sympathetic nerve activity to the kidneys, but not to the splanchnic
vascular bed, contributes to MAP regulation in genetically
hypertensive Schlager mice.
FUTURE RESEARCH
• Add additional mice to all experimental groups to increase 
statistical power
• Determine the effect of combined RDNx and CGx
• Explore the role of RDNx and CGx in BPN/3J (normotensive) mice
• Investigate the mechanism of these treatments
• Renal denervation (RDNx) has been shown to lower MAP 
in numerous animal models and in hypertensive patients
• Patients with hypertension have high muscle sympathetic 
nerve activity
• BPH/2J mice have high sympathetic nerve activity
• BPH/2J mice are found to be genetically hypertensive 
• The effect of celiac ganglionectomy (CGx) has also been 
studied in patients and animal models of hypertension, but 
not as widely
• BPH/2J animals have a high MAP
• RDNx lowers MAP (-13 +/- 2 mmHg)
• CGx also lowers MAP (-8 +/- 0.3 mmHg)
• HR is not affected differently by RDNx, CGx, or SHAM
• After treatments, hexamethonium had a greater drop in pressure 
for animals in the sham group than RDNx or CGx
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